Risk factors for cardiovascular disease — hypertension,
high low-density lipoprotein cholesterol
levels, hypertriglyceridemia, and microalbuminuria
— at baseline and at the end of the study
are shown in Table 1. The proportions of participants with these risk factors increased over time
and by the end of study were 33.8%, 10.3%, 28.2%,
and 16.6%, respectively. There were no significant
differences across treatment groups in newly identified
risk factors over equivalent person-years of
follow-up. No clinically apparent cardiac, renal,
neurovascular, or ophthalmologic complications
occurred during the trial.